Collectively, ketogenic diets’ roles in anti-tumor therapy remain generally unclear [55], however, our intervention demonstrated that a supervised ad libitum WFKD consumed for three months can significantly improve insulin sensitivity and mitigate common side-effects induced by anti-tumor medication. Here, INS is linked to neoplasm.